PTC (NASDAQ:PTC) vs. OptimizeRx (NASDAQ:OPRX) Head to Head Contrast

PTC (NASDAQ:PTCGet Free Report) and OptimizeRx (NASDAQ:OPRXGet Free Report) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.

Volatility & Risk

PTC has a beta of 0.98, indicating that its stock price is 2% less volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500.

Profitability

This table compares PTC and OptimizeRx’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
PTC 41.81% 25.84% 15.06%
OptimizeRx 6.37% 10.86% 7.93%

Valuation & Earnings

This table compares PTC and OptimizeRx”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
PTC $3.00 billion 5.35 $734.00 million $10.48 13.24
OptimizeRx $109.43 million 0.89 $5.13 million $0.35 14.83

PTC has higher revenue and earnings than OptimizeRx. PTC is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

95.1% of PTC shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 0.3% of PTC shares are held by company insiders. Comparatively, 5.6% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and target prices for PTC and OptimizeRx, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PTC 1 5 10 0 2.56
OptimizeRx 1 2 6 0 2.56

PTC currently has a consensus target price of $176.71, suggesting a potential upside of 27.38%. OptimizeRx has a consensus target price of $13.43, suggesting a potential upside of 158.74%. Given OptimizeRx’s higher possible upside, analysts plainly believe OptimizeRx is more favorable than PTC.

Summary

PTC beats OptimizeRx on 10 of the 14 factors compared between the two stocks.

About PTC

(Get Free Report)

PTC Inc. operates as software company in the Americas, Europe, and the Asia Pacific. The company provides Windchill, a suite that manages all aspects of the product development lifecycle(PLM) that provides real-time information sharing, dynamic data visualization, collaborate across geographically distributed teams, and enabling manufacturers to elevate product development, manufacturing, and field service processes; ThingWorx, a platform for Industrial Internet of Things; ServiceMax, a field service management solutions enable companies to asset uptime with optimized in-person and remote service and technician productivity with mobile tools. and deliver metrics; and Arena, a SaaS PLM solution enables product teams to collaborate virtually to share product and quality information with internal teams and supply chain partners and deliver products to customers. It offers Codebeamer, an application lifecycle management for products and software development; Servigistics, a service parts management solution; and FlexPLM, a solution provides retailers with a single platform for merchandising and line planning, materials management, sampling, and others. In addition, it offers Kepware, a portfolio of industrial connectivity solutions helps companies connect diverse automation devices and software applications; Creo, a 3D CAD technology enables the digital design, testing, and modification of product models; and Onshape, a cloud product development platform that delivers computer-aided design with data management tools. Further, it offers Vuforia, an augmented reality (AR) technology enables the visualization of digital information in a physical context and the creation of AR enabling companies to drive results in manufacturing, service, engineering, and operations; and Arbortext, a dynamic publishing solution streamlines how organizations create, manage, and publish technical documentation. PTC Inc. was incorporated in 1985 and is headquartered in Boston, Massachusetts.

About OptimizeRx

(Get Free Report)

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Receive News & Ratings for PTC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PTC and related companies with MarketBeat.com's FREE daily email newsletter.